A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate damaged p53. This crucial malignant suppressor protein is frequently lost in several forms of tumors, leading https://johsocial.com/story12669229/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-tumor-management